Wallin A - Search Results

1

White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study.

Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, Pantoni L, Fazekas F, Visser M, Waldemar G, Wallin A, Hennerici M, Inzitari D; LADIS Study. Verdelho A, et al. Among authors: wallin a. Neurology. 2010 Jul 13;75(2):160-7. doi: 10.1212/WNL.0b013e3181e7ca05. Neurology. 2010. PMID: 20625169

2

White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes.

Scheltens P, Erkinjunti T, Leys D, Wahlund LO, Inzitari D, del Ser T, Pasquier F, Barkhof F, Mäntylä R, Bowler J, Wallin A, Ghika J, Fazekas F, Pantoni L. Scheltens P, et al. Among authors: wallin a. Eur Neurol. 1998;39(2):80-9. doi: 10.1159/000007921. Eur Neurol. 1998. PMID: 9520068 Review.

3

Role of white matter lesions in cognitive impairment of vascular origin.

Pantoni L, Leys D, Fazekas F, Longstreth WT Jr, Inzitari D, Wallin A, Filippi M, Scheltens P, Erkinjuntti T, Hachinski V. Pantoni L, et al. Among authors: wallin a. Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S49-54. Alzheimer Dis Assoc Disord. 1999. PMID: 10609681 Review.

4

Subtypes of vascular dementia.

Rockwood K, Bowler J, Erkinjuntti T, Hachinski V, Wallin A. Rockwood K, et al. Among authors: wallin a. Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S59-65. Alzheimer Dis Assoc Disord. 1999. PMID: 10609683 Review.

5

Is subcortical vascular dementia a clinical entity for clinical drug trials?

Inzitari D, Erkinjuntti T, Wallin A, del Ser T, Pantoni L. Inzitari D, et al. Among authors: wallin a. Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S66-8. Alzheimer Dis Assoc Disord. 1999. PMID: 10609684 Review.

6

Nimodipine in subcortical vascular dementia trial.

Rossi R, Inzitari D, Pantoni L, del Ser T, Erkinjuntti T, Wallin A, Bianchi C, Badenas JM, Beneke M. Rossi R, et al. Among authors: wallin a. Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S159-65. Alzheimer Dis Assoc Disord. 1999. PMID: 10609696 Clinical Trial.

7

Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?

Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Desmond DW. Erkinjuntti T, et al. Among authors: wallin a. Ann N Y Acad Sci. 2000 Apr;903:262-72. doi: 10.1111/j.1749-6632.2000.tb06376.x. Ann N Y Acad Sci. 2000. PMID: 10818515

8

Subcortical vascular dementia as a specific target for clinical trials.

Inzitari D, Erkinjuntti T, Wallin A, Del Ser T, Romanelli M, Pantoni L. Inzitari D, et al. Among authors: wallin a. Ann N Y Acad Sci. 2000 Apr;903:510-21. doi: 10.1111/j.1749-6632.2000.tb06407.x. Ann N Y Acad Sci. 2000. PMID: 10818546 Review.

9

The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.

Pantoni L, Bianchi C, Beneke M, Inzitari D, Wallin A, Erkinjuntti T. Pantoni L, et al. Among authors: wallin a. J Neurol Sci. 2000 Apr 15;175(2):116-23. doi: 10.1016/s0022-510x(00)00301-4. J Neurol Sci. 2000. PMID: 10831772 Clinical Trial.

10

Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.

Pantoni L, Rossi R, Inzitari D, Bianchi C, Beneke M, Erkinjuntti T, Wallin A. Pantoni L, et al. Among authors: wallin a. J Neurol Sci. 2000 Apr 15;175(2):124-34. doi: 10.1016/s0022-510x(00)00300-2. J Neurol Sci. 2000. PMID: 10831773 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

711 results

Search Page

Filters